Senior insider sale
Chief Financial Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$10.78M
304.94K shares
What this filing means
GRUBER JAMES R. plans to sell 304.94K shares of ETON PHARMACEUTICALS, INC. valued at approximately $10.78M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0001974078-26-000256
Officer· Chief Financial Officer
Since Apr 2022
304.94K
Shares to sell
$10.78M
Approx. market value
251.82K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months6
Stock Option Exercies
Cash
6/26/2026
228.96KRSU
Cash
6/1/2026
6.88KRSU
Cash
1/13/2026
4.18KRSU
Cash
12/11/2025
7.08KRSU
Cash
12/11/2025
3.90KESPP
Cash
12/10/2025
822.00Total acquired251.82K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/26/2026 | Stock Option Exercies Cash | 228.96K | — |
6/1/2026 | RSU Cash | 6.88K | — |
1/13/2026 | RSU Cash | 4.18K | — |
12/11/2025 | RSU Cash | 7.08K | — |
12/11/2025 | RSU Cash | 3.90K | — |
12/10/2025 | ESPP Cash | 822.00 | — |
| Total | 251.82K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
25K
Market value
$875.3K
6/25/2026
—Completed
Units to sell
25K
Market value
$831.7K
6/23/2026
—Completed
Units to sell
3.12K
Market value
$84.0K
6/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
251.82K
Market value
$8.99M
6/26/2026
Total
Units
304.94K
Value
$10.78M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 25K | $875.3K | — | Completed |
6/23/2026 | 25K | $831.7K | — | Completed |
6/2/2026 | 3.12K | $84.0K | — | Completed |
| Planned — Approximate Date | ||||
6/26/2026 | 251.82K | $8.99M | Nasdaq | Planned |
| Total | 304.94K | $10.78M | ||